Electroacupuncture Facilitates Rapid Urinary Continence Recovery Post-Prostate Surgery
Electroacupuncture has been shown to significantly accelerate urinary continence recovery in men following prostatectomy, offering a promising adjunct to standard rehabilitation methods.
A recent clinical study has demonstrated that electroacupuncture significantly speeds up the process of regaining urinary control in men following radical prostatectomy, a common surgical treatment for localized prostate cancer. Published in JAMA Network Open on September 30, the study evaluated 110 men who experienced urinary incontinence—defined as using at least two pads daily—after robot-assisted prostate removal. Participants were randomly divided into two groups: one receiving electroacupuncture sessions three times a week over six weeks, and the other undergoing sham stimulation as a control.
The findings revealed that by the sixth week, the group treated with electroacupuncture showed a much higher rate of continence, with 43.6% achieving urinary control compared to only 21.8% in the sham group. This indicates that electroacupuncture can nearly double the likelihood of early recovery.
Researchers, led by Dr. Jiahui Niu from Nanjing University, suggest that incorporating electroacupuncture into postoperative rehabilitation could serve as a safe and effective adjunct to standard care, potentially reducing the burden of urinary incontinence during recovery.
These results support the integration of electroacupuncture into comprehensive treatment plans aiming to enhance quality of life and accelerate functional restoration after prostate cancer surgery.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Blood-Based Biosensor Promises Improved PTSD Diagnosis
Researchers have developed a novel blood-based biosensor using multiomic technology to enhance the accuracy and speed of PTSD diagnosis, paving the way for personalized mental health treatment.
Viral Protein from HIV Enhances Tuberculosis Risk in People with HIV
A recent study reveals how the HIV viral protein Tat impairs cellular defenses, increasing tuberculosis susceptibility in people living with HIV. Research insights highlight new therapeutic avenues to reduce co-infection risks.
Innovative Cancer Immunotherapy Brings New Hope for Advanced-Stage Patients
A groundbreaking Phase II clinical trial of PRL3-zumab reveals promising results in slowing disease progression in late-stage cancer patients unresponsive to traditional therapies, offering new hope for treatment-resistant cancers.
Arts Engagement as a Strategy to Prevent Major Non-Communicable Diseases
A large international study reveals that arts programs such as music, dance, and theater can play a vital role in preventing heart disease, diabetes, and other leading causes of death by promoting healthier behaviors and social connections.